21 September 2025 : Clinical Research
tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy
Zofia Twardochleb
ABCDEF 1, Marta Szczepańska ABCDEF 1, Maciej M. Miś CEF 2, Marcin Miś CEF 2, Adam Druszcz DEF 3,4, Małgorzata Paprocka-Borowicz ADEG 5,6*, Joanna Rosińczuk ADEFG 7
DOI: 10.12659/MSM.950237
Med Sci Monit 2025; 31:e950237
Table 4 Results of Token Test (TT).
| Group | Baseline (mean±SD) | Post-intervention (mean±SD) | % Improvement | p-value within group | p-value between-group |
|---|---|---|---|---|---|
| Group I (tDCS) | 32.7±5.8 | 41.4±5.6 | 26.7% | <0.001 | vs Group II: 0.02 |
| Group II (SLT) | 32.3±5.5 | 38.6±5.4 | 19.5% | <0.001 | vs Group III: 0.008 |
| Group III (tDCS+SLT) | 33.0±6.0 | 44.3±5.9 | 34.2% | <0.001 | vs Group I: 0.07 |
| tDCS – transcranial direct current stimulation; SLT – speech and language therapy. | |||||